Assignee
BIOPHYTIS
FR·8 granted patents·6 pending applications·6 citations·filing 2015–2023
Top patents by PatentIndex Score
14 records- 0176US9938315B2Chemical compounds and use thereof for improving muscular qualityBIOPHYTIS·Filed 2015·Granted Apr 10, 2018·3 cites·13 claims
- 0269US10316056B2Chemical compounds and use thereof for improving muscular qualityBIOPHYTIS·Filed 2018·Granted Jun 11, 2019·1 cites·15 claims
- 0365US11542295B2Use of 20-hydroxyecdysone and the derivatives thereof in the treatment of myopathiesBIOPHYTIS·Filed 2018·Granted Jan 3, 2023·1 cites·17 claims
- 0465US10513503B2Use of 3-deoxyanthocyanidins for treating occular diseasesBIOPHYTIS·Filed 2016·Granted Dec 24, 2019·1 cites·7 claims
- 0565US2023158046A1Phytoecdysones for use in the prevention of muscle strength loss during immobilisationBIOPHYTIS·Filed 2023·Application pending·0 cites
- 0656US2020148718A1Pharmaceutical-grade 20-hydroxyecdysone extract, use of same and preparation thereofBIOPHYTIS·Filed 2018·Application pending·0 cites
- 0756US2025207127A1Phytoecdysones and/or 20-hydroxyecdysone derivatives in combination with an active ingredient for restoring smn expression, for use in the treatment of spinal muscular atrophyBIOPHYTIS·Filed 2022·Application pending·0 cites
- 0856US2021369735A1Phytoecdysones for use in the prevention of muscle strength loss during immobilisationBIOPHYTIS·Filed 2019·Application pending·0 cites
- 0950US12551495B2Phytoecdysones and derivatives thereof for use in treating disordered respiratory function on viral infectionBIOPHYTIS·Filed 2021·Granted Feb 17, 2026·0 cites·11 claims
- 1046US12440500B2Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseasesBIOPHYTIS·Filed 2020·Granted Oct 14, 2025·0 cites·18 claims
- 1145US12215067B2Chemical compounds targeting the eye and use thereof in the treatment of eye diseasesBIOPHYTIS·Filed 2020·Granted Feb 4, 2025·0 cites·20 claims
- 1245US2022152060A1Phytoecdysones and the derivatives thereof for use in the treatment of impaired lung functionBIOPHYTIS·Filed 2020·Application pending·0 cites
- 1344US2017354638A1Bixa orellana composition for the treatment macular degenerationBIOPHYTIS·Filed 2017·Application pending·0 cites
- 1440US10314804B2Composition containing norbixin for protecting cells of the retinal pigment epitheliumBIOPHYTIS·Filed 2016·Granted Jun 11, 2019·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when BIOPHYTIS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →